Clazakizumab in Chronic Active Antibody-Mediated Kidney Transplant Rejection: Results of the IMAGINE Phase 3 Study

被引：0
|
作者：
Djamali, Arjang [1 ]
Bohmig, Georg [4 ]
Chadban, Steven J. [5 ]
Kumar, Deepali [6 ]
Mannon, Roslyn B. [7 ]
van Gelder, Teun [8 ]
Schultz-Hauser, Gabriele [9 ]
Alperovich Lehrer, Gabriela [10 ]
Preiss, Ralph [11 ]
Raychaudhuri, Aparna [2 ]
Lee, Laurie [2 ]
Nickerson, Peter W. [3 ]
机构：
[1] Maine Med Ctr, Portland, ME USA
[2] CSL Behring LLC, King Of Prussia, PA USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Med Univ Vienna, Vienna, Austria
[5] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Nebraska Med Ctr, Omaha, NE USA
[8] Leiden Univ Med Ctr, Leiden, Netherlands
[9] CSL Behring, Marburg, Germany
[10] CSL Vifor, Madrid, Spain
[11] CSL Behring, Bern, Switzerland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024ktr5vxvn
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-OR84
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation
    Kumar, D.
    Gupta, G.
    Reeve, J.
    Sanghi, P.
    Bobba, S.
    Levy, M.
    Bhati, C.
    Kimball, P.
    Fattah, H.
    King, A.
    Massey, H.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 310 - 310
  • [32] Antibody-mediated rejection in the kidney
    Racusen, LC
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 768 - 769
  • [33] Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab-A Preliminary Study
    Arrive, Capucine
    Jacquet, Marvin
    Gautier-Veyret, Elodie
    Jouve, Thomas
    Noble, Johan
    Lombardo, Dorothee
    Rostaing, Lionel
    Stanke-Labesque, Francoise
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [34] Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study
    Al Jurdi, A.
    Goldfarb, L.
    Lafargue, M.
    Azzi, J.
    Riella, L. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 728 - 728
  • [35] Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient
    Jordan, S. C.
    Vescio, R.
    Toyoda, M.
    Ammerman, N.
    Huang, E.
    Peng, A.
    Sethi, S.
    Najjar, R.
    Lim, K.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1062 - 1062
  • [36] REFRACTORY ANTIBODY-MEDIATED REJECTION IN KIDNEY-PANCREAS TRANSPLANT
    Xu, Jimmy
    Gorton, Lauren
    Neidich, Alon
    Craig, Julia
    Murphy, Katie
    Graff, Ralph
    Tuttle, Betsy
    Bastani, Bahar
    Horton, Peter
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A115 - A115
  • [37] Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
    Eskandary, Farsad
    Duerr, Michael
    Budde, Klemens
    Doberer, Konstantin
    Reindl-Schwaighofer, Roman
    Waiser, Johannes
    Wahrmann, Markus
    Regele, Heinz
    Spittler, Andreas
    Lachmann, Nils
    Firbas, Christa
    Muehlbacher, Jakob
    Bond, Gregor
    Halloran, Philipp F.
    Chong, Edward
    Jilma, Bernd
    Boehmig, Georg A.
    TRIALS, 2019, 20 (1)
  • [38] Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection
    Pineiro, G.
    Desousa, E.
    Villarreal, J.
    Lozano, M.
    Cid, J.
    Sole, M.
    Oppenheimer, F.
    Diekmann, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 536 - 536
  • [39] Current problems of chronic active antibody-mediated rejection
    Takeda, Asami
    Horike, Keiji
    Ohtsuka, Yasuhiro
    Inaguma, Daijo
    Goto, Norihiko
    Watarai, Yoshihiko
    Uchida, Kazuharu
    Morozumi, Kunio
    CLINICAL TRANSPLANTATION, 2011, 25 : 2 - 5
  • [40] THE PROGNOSTIC FACTORS IN CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION
    Zniber, A.
    Pernin, V.
    Ramouneau-Pigot, A.
    Kanouni, T.
    Serre, J. E.
    Garrigue, V.
    Eliaou, J. F.
    Mourad, G.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 8 - 8
12345